Magdalena Glice

Title: The Innovative Contributions of Magdalena Glice

Introduction

Magdalena Glice is a prominent inventor based in Warsaw, Poland. She has made significant contributions to the field of pharmaceuticals, particularly in the development of novel compounds and their synthesis. With a total of 2 patents, her work has garnered attention for its potential applications in medicine.

Latest Patents

One of her latest patents is focused on crystalline polymorphs of methanesulfonic acid addition salts of Imatinib. This invention relates to the methanesulfonic acid addition salts of Imatinib and to the synthesis thereof. In particular, it addresses the synthesis of the crystalline α-form of Imatinib methanesulfonate. Furthermore, the invention is directed to a novel acid addition salt of 4-(4-methylpiperazin-1-ylmethyl)-N-[4-methyl-3-[(4-pyridin-3-yl)pyrimidin-2-ylamino)phenyl]benzamide with two molecules of methanesulfonic acid and to the polymorphic forms thereof, as well as to their pharmaceutical compositions. Another significant patent involves methods for the preparation of olanzapine polymorphic form I. This invention provides new mixed solvates of olanzapine, which are valuable intermediates used in the preparation of pure olanzapine polymorphic form I.

Career Highlights

Throughout her career, Magdalena Glice has worked with notable institutions such as the Pharmaceutical Institute and the Pharmaceutical Institute. Her expertise in pharmaceutical sciences has led to advancements in drug formulation and development.

Collaborations

Magdalena has collaborated with esteemed colleagues, including Wieslaw Szelejewski and Urszula Fraczek. These partnerships have contributed to her innovative research and the successful development of her patents.

Conclusion

Magdalena Glice's contributions to the field of pharmaceuticals through her patents and collaborations highlight her role as an influential inventor. Her work continues to impact the development of important pharmaceutical compounds.